estrogen-regulated gene therapy (Signal/Organon)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nameestrogen-regulated gene therapy (Signal/Organon)
Drug Alias Namecardiovascular disease therapy (Signal/Organon)gynecological disease therapy (Signal/Organon)neurological disease therapy (Signal/Organon)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPsychotic DisordersNerve DegenerationCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research DivisionMSD Oss BV
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersNerve DegenerationCardiovascular Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A